Background: Rotavirus (RV) is the 5 th leading cause of death in children <5 years old but the 26 leading cause of diarrhea related deaths in this age group. The mechanism of RV diarrhea 27 involves decreased activity of Na + -dependent solute transporters with increased luminal 28 secretion of Clin the absence of significant histologic damage. While our understanding of RV 29 diarrhea has come from studies in animal models and cancer cell lines, the mechanism of the 30 diarrhea and the transport proteins affected in human RV disease remains only partially 31 understood. This understanding is likely to impact drug development therapy for RV diarrhea. 32 Methods: Formalin-fixed paraffin-embedded small intestinal specimens from patients diagnosed 33 with RV diarrhea (confirmed by anti-RV antibodies) were analyzed by immunofluorescence for 34 changes in apical/basolateral ion/nutrient transporters/channels as well as tight junctional and 35 cytoskeletal proteins. Proximal small intestinal enteroids generated from biopsies obtained from 36
to be caused by an effect on a common apical trafficking pathway, as exemplified by RV 48 diarrhea, and its contribution to other enteric pathogen-induced diarrheal diseases should be 49 determined. 50 51
INTRODUCTION: 52
In 2016, Rotavirus was the leading of diarrhea mortality in children <5 years old, causing 53 ~1 28,000 deaths, as well as the leading cause of overall diarrhea mortality worldwide, causing 54 ~2 28,000 deaths 1 . The markedly reduced efficacy of oral RV vaccines in developing countries 55 (39-49%), relative to the United States (90%), is one reason why overall RV-associated 56 childhood death has fallen by only ~3% 2,3 . Oral rehydration solution (ORS) can be effective in 57 RV diarrhea, but is used in <50% of cases. New approaches to RV diarrhea protection and 58 therapy are, therefore, desperately needed. 59 60 RV preferentially infects differentiated enterocytes and enteroendocrine cells of the small 61 intestine to induce a self-limiting, non-inflammatory diarrhea. The mechanisms identified as being involved in acute RV diarrhea include malabsorption, due to decreased enterocyte 63 absorption, and increased fluid secretion induced by the RV enterotoxin, NSP4 4-6 . NSP4 is a 64 virus-encoded ion channel that depletes Ca 2+ from the ER of infected cells leading to stimulation 65 of store operated Ca 2+ entry to sustain elevated levels of intracellular Ca 2+ that is critical for RV 66 replication. RV transiently stimulates Clsecretion and since RV diarrhea occurs in models of 67 cystic fibrosis, the Clchannel involved is unlikely to be CFTR 7 . Moreover, in a mouse model of 68 RV diarrhea, a Ca 2+ activated Clchannel inhibitor prevented RV diarrhea 8 . Activity of Na + -69 solute cotransporters, such as SGLT1, and the Na + /H + exchanger, NHE3, are also reduced in 70 RV 9,10 . Whether a common mechanism explains the changes in so many apical transport 71 processes is not known. Despite studies using human colon cancer-derived cell lines and 72 animal intestines (e.g. mice, rats, cats), there are no detailed studies using intestinal tissues 73 from patients documented to have RV diarrhea. We and others have demonstrated that RV 74 pathogenesis can be studied using human enteroids, which are self-propagating primary 75 cultures of normal human small intestinal epithelium derived from intestinal stem cells obtained 76 from healthy donors 11 . 77 78
In this report, we analyzed pathology specimens of intestine from patients with documented RV 79 diarrhea to describe a new mechanism for RV diarrhea that explains many of the previously 80 reported effects on intestinal transport. We also demonstrate that a similar phenotype occurs in 81 RV infected human enteroids, supporting future pathophysiologic studies in human enteroids 82 and identifying a model to use for development of anti-RV diarrheal drugs. 83 84
METHODS: 85

Identification of intestinal pathology specimens of cases of rotaviral diarrhea: A text for 86
the term "rotaviral diarrhea" was applied to the University of Chicago Department of Pathology 87 records, and formalin-fixed, paraffin-embedded (FFPE) intestinal biopsies were obtained. Similar numbers of disease-free biopsies from age (ages 2-22) and sex matched controls 89 processed contemporaneously with the RV specimens were collected to serve as controls for 90 processing and storage effects. 91 92
Antibodies: Rabbit polyclonal RV antibodies against outer capsid protein, VP6 (1:50 dilution) 93 and RV enterotoxin, NSP4 (1:100 dilution), have been previously described 4 . Rabbit polyclonal 94 antibody to: NHE3 (SLC9A3) was from Novus Biologicals (Cat #: NBP1-82574);; NHE2 95 (SLC9A2) 14 ;; B o AT1 (SLC6A19) was from Sigma (Cat #: HPA043207);; zonula occludins 1 (ZO-96 1) was from Invitrogen (Cat #: 33-9100);; and β-catenin were from R&D Systems. Mouse 97 monoclonal antibodies to: CFTR (clone M3A7;; Cat #: 05-583) and SGLT-1 (Cat #: 07-1417) 98
were from Millipore;; NKCC1 (SLC12A2;; Cat #: T4) and Na + /K + -ATPase (Cat #;; a5) were from 99 the University of Iowa Developmental Studies Hybridoma Bank. Rabbit monoclonal anti-100 phospho-ezrin (p-T567) was from Abcam (Cat #: EP2122Y).
102
Human Rotavirus: Human RV strain, Ito, was replicated in MA104 cells, purified, and infected 103 in human enteroids as previously described 11 . 104 105
Human enteroids: 106
Human duodenal and jejunal enteroids were each established from four healthy donors (ages 2-107 22) obtained via endoscopic or surgical procedures utilizing the methods developed by the 108 Clevers laboratory 15 . De-identified biopsy tissue was obtained from healthy subjects who 109 provided informed consent at Johns Hopkins University and all methods were carried out in 110 accordance with approved guidelines and regulations. All experimental protocols were approved 111 by the Johns Hopkins University Institutional Review Board (IRB#: NA_00038329 and 112 IRB00044373). Briefly, enteroids generated from isolated intestinal crypts 16 were maintained as 113 cysts embedded in Matrigel (Corning, USA) in non-differentiation media (NDM) containing Wnt3A, R-spondin-1, noggin and EGF, as we have described previously 17 . Enteroid 115 monolayers were generated as previously described in detail 17,18 . Monolayer differentiation 116 was induced by incubation in Wnt3A-free 20 and Rspo-1-free DFM for five days 17 . Monolayer 117 confluency and differentiation were monitored by measuring TER with an ohmmeter (EVOM 2 ;; 118
World Precision Instruments, USA). The unit area resistances (ohm-cm -2 ) were calculated 119 considering Transwell surface area (0.33 cm 2 ) 17,18 . 120
Immunofluorescence confocal microscopy: FFPE blocks were sectioned to 5µm and 121 rehydrated through an ethanol gradient prior to microwave antigen retrieval in 10mM sodium 122 citrate (pH 6.0). For enteroids, monolayers were fixed in 2% paraformaldehyde in PBS for 30 123 minutes. Sections and monolayers were blocked and permeabilized in PBS containing 2% 124 BSA, 15% FBS, and 0.1% saponin for 1 hour and then washed three times in PBS. Primary 125 antibodies (1:100 dilution) in PBS were incubated overnight at 4℃ followed by three PBS 126 washes. Cells were then incubated with anti-mouse or anti-rabbit AlexaFluor (488nm or 568nm) 127 
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RESULTS: 169
Validation of RV infection in pathology specimens: Cases previously diagnosed as rotaviral 170 diarrhea and controls were analyzed by immunofluorescence confocal microscopy. Of 17 cases 171 initially categorized as RV diarrhea, 12 cases were confirmed positive for rotaviral infection on 172 the basis of immunofluorescent staininng for both VP6 and NSP4. Neither protein was detected 173 in any of the the healthy controls (Fig  1) . These 12 cases were studied further. 174 175
RV diarrhea is associated with altered localization and/or expression of brush border 176
ion/nutrient transporters and channels: Immunofluorescence confocal microscopy revealed 177 major differences in brush border/apical transport proteins exhibiting mislocalization away from 178 the brush border as well as reduced expression in RV specimens compared to healthy controls. 179
This was true of NHE2, NHE3, CFTR, SGLT1, and B o AT1 (SLC6A19) (Fig  2A,  B and Table  1) . 180 SGLT1 localization was subapical while CFTR, NHE2 and SLC6A19 were redistributed towards 181 the basolateral pole of epithelial cells. The overall expression of NHE3 in enterocytes was 182 nearly lost. In some cases, expression of NHE2, SGLT1 or CFTR could also not be detected 183 (Fig  2A) . In order to confirm that these changes were not due to general structural changes in 184 the brush border, which appeared normal by histologic analysis, we examined expression and 185 localization of phosphorylated (T567) ezrin (i.e. p-ezrin), a brush border structural protein, as 186 well as tight junction (TJ) markers ZO1 and occludin. The location and magnitude of p-ezrin 187 and ZO-1 expression were not affected rotavirus infection, relative to healthy controls (Fig  3,  188 Table 1). To consider whether there was a general abnormality of transport protein expression 189 or localization, the basolateral transport proteins NKCC1 and Na + /K + -ATPase as well as β-catenin (data not shown) were studied. No changes in these proteins were identified (Figs 3, 4, 191 Table  1) human RV with mock infected enteroids as negative controls, as described previously 11 . The 219 conditions studied were associated with RV infection (~40% infected cells similar to previously 220 shown 11 ) as indicated by presence of virus visualized by transmission electron microscopy 221 within 1 hour post infection ( Fig  5) . Monolayers were fixed at multiple times after RV infection 222 infected for 1-48 hours. As summarized in Table  2 , RV significantly downregulated expression 239 of multiple apical trafficking proteins including the apical cargo trafficking motor protein, myosin 240
Vb, and Ras associated binding (Rab) proteins, and associated binding partners that regulate 241 cargo trafficking via the apical endosome.
243
DISCUSSION: 244
The findings of this study define the impact of RV infection on the expression and 245 localization of the major intestinal epithelial ion/nutrient transporters/channels in human 246 intestinal tissue. We observed that multiple apical transport proteins, including Na + -dependent 247 ion/solute transporters and the major intestinal chloride secretory channel, CFTR, are either 248 mislocalized and, in some cases, downregulated in the small intestine of patients with RV 249 diarrhea when compared to specimens from healthy subjects. These changes in 250 expression/localization appeared to be specific for apical transporters/channels since 251 basolateral transporters, as well as tight junctional proteins, were normally distributed in RV 252 patient specimens. Moreover, the changes observed in clinical specimens can be reproduced 253 in a primary human in vitro epithelial culture system (i.e. enteroids). Due to the specific effects 254 of RV infection on apical transporters, our data suggest that a common apical trafficking 255 pathway shared by multiple transporters/channels may be the mechanism responsible for RV 256 diarrhea.
258
Previous studies of RV diarrhea have separately addressed RV effects on individual 259 transporters. Together, these data have suggested the RV diarrhea occurs due to increased Cl -260 secretion and defective Na + absorption. The results of our study unify previous findings by 261 examining how RV alters the expression/localization of multiple transporters in human enteroids 262 and comparing these phenotypes to clinical specimens from RV infected patients. Here we 263
show that RV diarrhea appears to be due to mild changes in the brush border, seen by EM but 264 not by light microscopy and not associated with changes in expression of the brush border 265 protein p-ezrin or the tight junction protein ZO-1, plus abnormal apical membrane trafficking of 266 transport proteins. The abnormal trafficking of the proteins identified in this study, would 267 account for the documented reduced Na + and glucose absorption (reduced apical SGLT1, NHE3), occurrence of diarrhea in CF models (CFTR not apically localized), and ability of the 269 calcium activated Clchannel inhibitor 8 to totally prevent RV diarrhea in a neonatal mouse 270 model. However, the calcium activated Clchannel involved in small intestinal secretion has not 271 been identified molecularly. Consequently, we cannot determine if that protein is also 272 mislocalized or down-regulated;; although, the results suggest it is trafficked differently than the 273 affected proteins. The fact that ORS is marginally effective in rehydrating patients with RV 274 diarrhea is at least partially explained by the fact that RV infection reduces the overall amount of 275 transporters that could respond to ORS. However, the fact that ORS saves lives in RV diarrhea 276 speaks for the fact that the transport processes involved in ORS related rehydration (SGLT1, 277 NHE3, Na + /K + -ATPase) are still at least partially functional, which is consistent with the previous 278 documentation of patchy histologic changes in small intestine of RV diarrhea.
280
The current report potentially identifies a previously unrecognized mechanism of diarrhea that 281 might be relevant for additional difficult to treat diarrheas;; however, the precise mechanism 282 involved abnormal apical trafficking remains to be determined. To support the hypothesis that 283 apical trafficking is the general mechanism responsible, we identified a panel of apical 284 endosome associated proteins that are significantly downregulated following RV infection in 285 human enteroids (Table  2) are not likely to be successful.
303
Importantly, the reproduction in human enteroids of the RV effects on apical trafficking and 304 transport protein expression in the human disease provides a model for additional mechanistic 305 studies and potential drug development to treat RV diarrhea. We recently established the 306 methodology to grow human enteroids as confluent 2D monolayers to generate a controllable 307 and tractable model to study luminal host-pathogen interactions and standardized this model to 308 allow separate study of a "villus"-like epithelium (differentiated enteroids) and "crypt"-like 309 epithelium (undifferentiated enteroids) 17,18 . Furthermore, we showed that RV preferentially 310 targets differentiated enteroids, which is consistent with the previous recognition that RV 311 preferentially infects villus tip enterocytes 20 . We further established that human enteroids 312 demonstrate intracellular changes typical of RV replication in cultured cells, including 313 visualization of nascent virus particles within intracellular vesicles by electron microscopy 314 ( Figure  4) , some microvillar damage, the induction of lipid droplets, and formation of replication 315 compartments 11 . 316 317
While RV is the first diarrheal disease to act by causing a defect in the general apical trafficking 318 mechanism, it will be important to determine how wide-spread is the contribution of this 319 mechanism to other diarrheal diseases and to diseases of other epithelia (lung, kidney, brain, etc 
